SPC294
Netúpítant eða fosnetúpítant í samsetningu með palónósetron
Status:
UmsóknApplication date:
11.5.2020Application published:
15.5.2020
Max expiry date:
17.3.2035Medicine name:
AkynzeoMedicine for children:
No
Timeline
Today
11.5.2020Application
15.5.2020Publication
17.3.2035Expires
Marketing license
Foreign authorization number:
EU/1/15/1001Date:
16.3.2020
Owner
Name:
Helsinn Healthcare SAAddress:
Via Pian Scairolo 9, Lugano-Pazzallo CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2785706